Construction of novel procoagulant protein targeting neuropilin-1 on tumour vasculature for tumour embolization therapy
Construction of novel procoagulant protein targeting neuropilin-1 on tumour vasculature for tumour embolization therapy
复制标题
构建针对肿瘤血管系统的 Neuropilin-1 的新型促凝血蛋白用于肿瘤栓塞治疗
DOI:
10.1080/1061186x.2019.1566337
复制
发表时间:
2019-01
影响因子:
4.5
通讯作者:
Yan Jianghua
中科院分区:
文献类型:
--
作者:
Zou Mingyuan;Samiullah Malik;Xu Peilan;Wang Shengyu;He Jie;Wu Ting;Luo Fanghong;Yan Jianghua
Abstract The cellular transmembrane receptor Neuropilin-1(NRP-1) is overexpressed in tumour tissue and endothelial cells of tumour vessels, whereas it has limited expression in normal tissues. This study aimed to design a novel recombinant protein tTF-EG3287, which consisting of the truncated tissue factor (tTF) and the NRP-1 targeting peptide EG3287. The procoagulant protein selectively activates blood coagulation in tumour vessels once bound to the cell surface of the tumour vasculature by a targeting peptide EG3287. In this study, procoagulant activity of the recombinant protein tTF-EG3287 was evaluated by Spectozyme FXa assay. NRP-1 targeting ability was analysed by fluorescence confocal microscopy and flow cytometry. The living imaging system was used to assess the tumour targeting ability of recombinant proteins tTF-EG3287 in vivo. Tumour growth inhibition showed effective antitumor activity in HepG2 tumour-bearing nude mice. Histological study showed obvious thrombosis and thromboembolism in tumour vessels and cell necrosis of tumour tissue, without any clear side effect such as thrombosis in other organs.
登录
查看更多内容
影响因子:
14.8
作者:
Kelley LA;Mezulis S;Yates CM;Wass MN;Sternberg MJ
通讯作者:
Sternberg MJ
影响因子:
7.4
作者:
Luo Y;Zhang B;Chen M;Jiang T;Zhou D;Huang J;Fu W
通讯作者:
Fu W
影响因子:
11.2
作者:
Janice M. Y. Brown;A. Giaccia
通讯作者:
Janice M. Y. Brown;A. Giaccia
影响因子:
5.5
作者:
Huleatt, James W.;Jacobs, Andrea R.;Powell, T. J.
通讯作者:
Powell, T. J.
影响因子:
2.9
作者:
He, Qing;Gong, Kai;Zhang, Xiufang
通讯作者:
Zhang, Xiufang